Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03613324
Other study ID # 201805025RINB
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2011
Est. completion date May 31, 2018

Study information

Verified date July 2018
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prevalence rates of bladder outlet obstruction (BOO) and detrusor underactivity (DU) and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.


Description:

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Only those with complete data of maximum flow rate (Qmax) and detrusor pressure at maximum flow rate (PdetQmax) were enrolled. ANOVA test and post-hoc testing with bonferroni's correction were used for statistical analysis. Woman were defined as having DU when Qmax was <12 mL/s and PdetQmax was <10 cmH2O, and were defined as having BOO when Qmax was <12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.


Recruitment information / eligibility

Status Completed
Enrollment 455
Est. completion date May 31, 2018
Est. primary completion date November 30, 2017
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

1. Age > 20y/o

2. Cystocele > stage II

3. Complete pad test and urodynamic study

Exclusion Criteria:

1. Pregnancy

2. Urinary tract infection

3. Had received pelvic reconstruction surgery

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Pad test
20-minutes pad test and urodynamic study including uroflowmetry, filling cystometry and voiding cystometry.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary BOO Bladder outlet obstruction: Qmax was <12 mL/s and PdetQmax was =25 cmH2O with sustained detrusor contraction during voiding cystometry. November 2011 to January 2017
Primary DU Detrusor underactivity: <12 mL/s and PdetQmax was <10 cmH2O November 2011 to January 2017